Home › Funds › Washington Trust Advisors, Inc. › AXSM
Washington Trust Advisors, Inc. position in AXSM
AXSOME THERAPEUTICS INC. · Health Care
Washington Trust Advisors, Inc. reported holding 43,963 shares of AXSM (AXSOME THERAPEUTICS INC.) in its Q3 2026 13F filing — a position valued at US$8.1M, representing 0.58% of its reported portfolio and ranking #43 among its reported holdings. Washington Trust Advisors, Inc. has disclosed AXSM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Washington Trust Advisors, Inc.'s AXSM position evolved
Washington Trust Advisors, Inc. first disclosed a stake in AXSM in Q4 2023 at 330 shares (US$26K). The position peaked in Q3 2026 at 43,963 shares, worth US$8.1M. Across 12 filings, Washington Trust Advisors, Inc. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 43,963 shares valued at US$8.1M — an increase of 43,788 shares quarter over quarter.. Notable position changes include a 30% trim in Q2 2026 (shares fell 25% over the following quarter), a 25022% increase in Q3 2026 (shares fell 23% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 330 | $26.27K | New |
| Q1 2024 | 330 | $26.33K | Hold |
| Q2 2024 | 330 | $26.57K | Hold |
| Q3 2024 | 330 | $29.66K | Hold |
| Q4 2024 | 330 | $27.92K | Hold |
| Q1 2025 | 250 | $29.16K | Reduce |
| Q2 2025 | 250 | $26.10K | Hold |
| Q3 2025 | 250 | $30.36K | Hold |
| Q4 2025 | 250 | $45.66K | Hold |
| Q1 2026 | 250 | $42.26K | Hold |
| Q2 2026 | 175 | $42.84K | Reduce |
| Q3 2026 | 43.96K | $8.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AXSM and 13F data
AXSM (AXSOME THERAPEUTICS INC.) is a Health Care company. 50 other funds we track also report a position in AXSM — the largest reported positions include Deep Track Capital, LP (US$171.3M), ALETHEA CAPITAL MANAGEMENT, LLC (US$119.7M), Hood River Capital Management LLC (US$98.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AXSM
- Deep Track Capital, LP 700.00K sh · $171.34M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 649.12K sh · $119.69M · Q3 2026
- Hood River Capital Management LLC 402.68K sh · $98.56M · Q2 2026
- EVENTIDE ASSET MANAGEMENT, LLC 316.82K sh · $77.53M · Q2 2026
- Integral Health Asset Management, LLC 300.00K sh · $73.43M · Q2 2026
- FRONTIER CAPITAL MANAGEMENT CO LLC 254.28K sh · $62.24M · Q2 2026
- SAMLYN CAPITAL, LLC 246.01K sh · $60.22M · Q2 2026
- PFM Health Sciences, LP 219.60K sh · $53.75M · Q2 2026
- Tri Locum Partners LP 219.31K sh · $53.68M · Q2 2026
- First Turn Management, LLC 218.41K sh · $53.46M · Q2 2026
- Cannell & Spears LLC 259.65K sh · $47.88M · Q3 2026
More on Washington Trust Advisors, Inc.
FAQ
How long has Washington Trust Advisors, Inc. held AXSM?
Washington Trust Advisors, Inc. has disclosed AXSM holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Washington Trust Advisors, Inc.'s current position in AXSM?
As of Q3 2026, Washington Trust Advisors, Inc. holds 43.96K shares of AXSM (AXSOME THERAPEUTICS INC.), valued at $8.11M, representing 0.58% of its reported portfolio and ranking #43.
Has Washington Trust Advisors, Inc. been buying or selling AXSM?
In the latest 13F filing (Q3 2026), Washington Trust Advisors, Inc. increased its position in AXSM. The position peaked in Q3 2026 at 43.96K shares.
Which other funds hold AXSM?
Other major institutional holders of AXSM include Deep Track Capital, LP, ALETHEA CAPITAL MANAGEMENT, LLC, Hood River Capital Management LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.